Merck Builds On Januvia Momentum With Two Supplementary Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
Recently announced sNDAs have October action dates and seek indications relating to initial and add-on use with metformin or sulfonylureas.
You may also be interested in...
Janumet Approved; Type 2 Diabetes Therapy Will Be Available By End Of April
Price for the Januvia/metformin combo will be the same as for Januvia alone, Merck tells “The Pink Sheet” DAILY.
Janumet Approved; Type 2 Diabetes Therapy Will Be Available By End Of April
Price for the Januvia/metformin combo will be the same as for Januvia alone, Merck tells “The Pink Sheet” DAILY.
Merck’s Januvia Scores European Approval
Firm also awaiting a decision in the U.S. on sitagliptin/metformin combination Janumet, expected this week.